Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 10, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 12, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001739515-26-000006
Filed / recorded
Mar 12, 2026, 8:22 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
GILEAD SCIENCES, INC.
Issuer CIK
882095
Ticker
GILD
Reporting person
Dietmar Berger
Relationship
Officer
Officer title
Chief Medical Officer
Security
Non-qualified Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Mar 10, 2026
Transaction code
A
Shares / units
31,475
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
31,475
Ownership form
Direct
Amendment
No
Footnotes from the filing
The stock options have a four-year vesting schedule. 25% of the options vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.